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Abstract
Turner syndrome (TS) is a chromosomal condition associated with partial or complete absence of 
the X chromosome that involves characteristic findings in multiple organ systems. In addition to 
well-known clinical characteristics such as short stature and gonadal failure, TS is also associated 
with T cell immune alterations and chronic otitis media, suggestive of a possible immune 
deficiency. Recently, ubiquitously transcribed tetratricopeptide repeat on the X chromosome 
(UTX), a histone H3 lysine 27 (H3K27) demethylase, has been identified as a downregulated gene 
in TS immune cells. Importantly, UTX is an X-linked gene that escapes X-chromosome 
inactivation and thus is haploinsufficient in TS. Mice with T cell-specific UTX deficiency have 
impaired clearance of chronic viral infection due to decreased frequencies of T follicular helper 
(Tfh) cells, which are critical for B cell antibody generation. In parallel, TS patients have 
decreased Tfh frequencies in peripheral blood. Together, these findings suggest that 
haploinsufficiency of the X-linked UTX gene in TS T cells underlies an immune deficit, which 
may manifest as increased predisposition to chronic otitis media.
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Introduction
Turner syndrome (TS) is a common chromosomal abnormality, occurring in about 1:4000 
live births, which describes phenotypic females with either partial or complete absence of 
one sex chromosome [1]. TS is named for Dr. Henry Turner who in 1938 described seven 
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women with short stature, sexual immaturity, cubitus valgus, webbed neck, and low 
posterior hairline [2]. In the mid 1950s, advances in cytogenetic identification allowed the 
discovery that patients with TS have one normal X chromosome and a missing or 
structurally altered sex chromosome [3]. In 1965, after analyzing hundreds of karyotypes of 
patients with various forms of gonadal dysgenesis, Dr. Malcolm Ferguson-Smith proposed 
that short stature and other TS clinical findings were due to gene deletions from the missing 
short arm of the X chromosome [4]. This hypothesis was largely validated in subsequent 
years [5].
In non-Turner 46 XX females, one copy of the X chromosomes is inactivated to achieve 
some degree of balanced gene expression between males and females. Thus, absence of one 
sex chromosome, on the surface, would not be predicted to have any effect. However, X 
inactivation is incomplete; 15 % of the genes on the silenced X chromosome escape 
inactivation and are expressed from both chromosomes [6]. Most genes escaping X 
inactivation are pseudoautosomal genes located on the short arm of the X chromosome and 
have homologous genes on the Y chromosome. Therefore, most abnormalities seen in TS 
are thought to be due to haploinsufficiency of genes that are normally expressed by both X 
chromosomes (Fig. 1a) [1, 6].
Strong evidence for the concept that pseudoautosomal genes underlie TS findings came from 
the identification of short stature homeobox-containing gene (SHOX) as the underlying 
cause of short stature in TS. SHOX is a pseudoautosomal gene that escapes X inactivation 
and is highly expressed in osteogenic tissue [7, 8]. Mutations in SHOX cause familial short 
stature in a dominant fashion, suggesting that a quantitative decrease in the SHOX gene 
product is sufficient to decrease linear growth [9, 10]. Thus, SHOX haploinsufficiency in TS 
is a major contributor to growth failure in TS [8, 11]. Together, this evidence suggests that 
the absence of the genetic material from the missing sex chromosome results in TS clinical 
findings. However, other pseudoautosomal X-linked genes that contribute to the TS 
phenotype remain to be identified.
A deeper understanding of the genetic underpinning of TS and associated clinical features 
are needed for the development of better prevention, treatment, and anticipatory guidance 
strategies for TS patients and their families. An area in need of study is the potential 
alterations in the TS immune system. This review will discuss the current literature 
regarding TS and associated immune abnormalities and will highlight the role of a 
pseudoautosomal gene UTX recently discovered to affect CD4+ T cell differentiation and 
immune defenses against chronic viral infection.
Turner Syndrome May Be Associated with Immune Abnormalities
TS patients are predisposed to a wide array of clinical findings, including frequent otitis 
media (OM) (Table 1). The pathogenic mechanism underlying this susceptibility to OM is 
unclear. One hypothesis is that craniofacial features of TS predispose to chronic OM [12]. 
Another hypothesis that is not mutually exclusive is that an underlying immune deficiency 
may be a component of TS and contribute to chronic OM. Consistent with this latter 
possibility, TS patients have been reported to have immune alterations in T cell and 
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immunoglobulin subsets. These include decreased levels of circulation T and B 
lymphocytes, reduced levels of serum IgG and IgM, and increased IgA [13–15]. However, 
other studies did not find major immunological deficiencies in TS subjects [16, 17, 18•]. 
Thus, more research focused on immune alterations in TS subjects is needed to resolve these 
discrepancies. A confounder for these analyses is that frequent infections, such as in TS, 
may cause elevated immune activation compared to non-TS controls. Thus, a careful 
experimental design which take such confounders into consideration is essential.
TS Patient Immune Cells Express Decreased UTX, a Histone-Modifying 
Enzyme
To determine whether gene expression in immune cells were altered in TS and also to 
identify potential pseudoautosomal X-linked genes that contribute to immune alterations, 
Cook et al. performed a microarray analysis on peripheral blood mononuclear cells 
(PBMCs) comparing gene expression in control females to TS subjects with confirmed 45X 
karyotype [19••]. A total of 1169 unique genes showed differential expression in TS 
PBMCs, including 35 on the X chromosome. In particular, ubiquitously transcribed 
tetratricopeptide repeat on chromosome X (UTX, encoded by Utx or Kdm6a located at 
Xp11.3 [20]) was among the top 10 X-linked genes with the largest decrease in expression 
and the only gene among these candidates that escapes X inactivation [21].
UTX is part of the Jumonji D3 (Jmjd3) family of histone H3 lysine 27 (H3K27) 
demethylases that epigenetically regulates gene expression (Fig. 1b) [22]. Epigenetic 
regulation refers to heritable changes in gene expression that do not involve changes in the 
DNA sequence. Lineage specification is maintained by epigenetic changes that are retained 
in cells and daughter cells after cell division. For example, chromatin modifications alter the 
accessibility of genes to transcription factors and RNA polymerases, thus directly impacting 
gene expression [23]. Chromatin, the condensed packaging of DNA within eukaryotic cells, 
consists of nucleosomes that contain 146 base pairs of DNA tightly wound around histones. 
These histones contain amino acid residues exposed around the nucleosome core, or “tails,” 
that can be biochemically modified at sites of gene promoters and enhancers. These histone 
modifications are associated with gene expression or gene silencing. Histone H3 lysine 27 
trimethylation (H3K27me3) is a transcriptionally repressive modification typically found in 
heterochromatin or transcriptionally silenced loci. UTX, as a H3K27 demethylase, removes 
trimethylated and dimethylated groups at H3K27 residues, thus increasing gene expression. 
UTX is ubiquitously expressed and plays a major role in several cell processes, such as 
embryonic development [24, 25], cell cycle regulation [26], hematopoiesis [27], and cancer 
pathogenesis [28, 29]. However, the role of UTX in immune cells was largely unknown.
CD4+ T cells have also been described to undergo epigenetic modifications during T cell 
differentiation into T helper subsets (e.g., Th1, Th2, Th17, Treg, Tfh) to ensure a heritable 
gene expression program specific to each subset [23]. A genome-wide study of H3K27 
methylation in both naïve and differentiated T cell subsets revealed that upregulation of 
subset-defining transcription factors, effector molecules, and cytokine was associated with 
decreased repressive H3K27me3 marks at these gene regions [30]. Although these findings 
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suggested a potential role for UTX in epigenetic regulation of T cell differentiation, whether 
UTX actually mediated any of these changes was unclear.
UTX Deficiency in T Cells Prevents Tfh Differentiation and Eradication of 
Chronic Viral Infection
To investigate the role of UTX in T cells in the immune system, Cook et al. turned to genetic 
mouse models of UTX deficiency. Because UTX knockout mice are embryonic lethal [24, 
25], Cook et al. engineered mice with T cell-specific deletion of UTX to determine how 
decreased UTX may affect T cell function [19••]. Mice with T cell-specific UTX deficiency 
show normal clearance of acute viral infection but impaired clearance of chronic viral 
infection. Furthermore, mice that are heterozygous for T cell-specific UTX deficiency show 
partially attenuated viral loads, suggesting a dose-dependent UTX function in clearance of 
chronic viral infection [19••].
During chronic viral infection, CD4+ T helper cells play an important role in boosting the 
CD8+ cytotoxic T cells and B cell-mediated adaptive immune response. Differentiation of 
CD4+ T cell to the T follicular helper (Tfh) subset, in particular, is critical for generating an 
appropriate B cell antibody response as revealed by several human genetic 
immunodeficiencies [31]. T follicular helper cells interact with immature B cells within 
follicles of secondary lymphoid tissues to promote B cell somatic hypermutation, class 
switching, and IgG antibody formation [32–35]. In T cell UTX-deficient mice, the impaired 
immunity to chronic viral infection was associated with decreased Tfh subset differentiation 
and fewer germinal centers [19••]. As a consequence, B cell IgG production was also 
impaired [19••]. Interestingly, UTX deficiency in T cells was associated with increased 
H3K27me3 at genes (e.g., IL6R) important in Tfh differentiation. Therefore, UTX supports 
Tfh cell differentiation through demethylation of Tfh signature genes, a process required for 
eliminating chronic viral infection.
TS Patients Have Decreased Tfh Cells
Following infection, otitis-prone children display reduced cytokine-secreting memory T 
cells and a poor IgG response relative to children not prone to OM, suggesting poor Tfh cell 
help to B cell antibody responses in children with chronic OM [36]. It was unclear whether 
TS patients also have an increased predisposition to chronic OM due to decreased Tfh cells. 
Although T cell UTX deficiency in mice results in fewer Tfh cells, it was not known 
whether UTX deficiency in TS subject immune cells would translate to decreased Tfh cells. 
In humans, CD4+CXCR5+ cells in peripheral blood are associated with antibody production, 
which allows them to serve as a measurable substitute of Tfh [37]. The frequency of 
CD4+CXCR5+ T cells were reduced by twofold in TS subjects compared to controls [19••]. 
This suggests that decreased UTX expression in TS patients might increase their 
predisposition to viral infections due to Tfh cell deficiency and subsequent low antibody 
levels. Overall, these data suggest that UTX haploinsufficiency in TS patient immune cells 
has functional consequences: decreased Tfh cells, a subset important in the clearance of 
chronic OM.
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Other Roles for UTX in T Cells
In addition to its effects on Tfh differentiation, UTX is also important for T cell maturation 
and immune homeostasis. For example, T cell-specific deficiency in both UTX and Jmjd3 
(UTX and Jmjd3 double deficiency) prevents thymic egress of T cells resulting in increased 
numbers of CD4SP mature thymocytes and decreased peripheral T cells [38••]. This effect 
was associated with increased H3K27me3 at the S1PR1 promoter and a corresponding 
decrease in surface expression of S1PR1, which is required for mature thymocytes to exit the 
thymus [38••]. Furthermore, demethylase-defunct UTY failed to rescue CD4SP thymocyte 
S1PR1 expression in UTX and Jmjd3-deficient males, supporting the notion that H3K27 
demethylase activity directly results in S1PR1 expression [38••]. Accumulation of thymic 
CD4SP thymocytes was not noted in mice with T cell-specific UTX deficiency by itself 
[19••], suggesting that Jmjd3 may be able to compensate, at least in part, for UTX deficiency 
during T cell thymic egress.
In addition to its H3K27 demethylase activity, UTX can also regulate gene expression in a 
demethylase-independent manner through protein interactions with chromatin remodeling 
complexes, such as Brg1, and transcriptional protein complexes. For example, UTX interacts 
with Th1-specific transcription factor T-bet and the Brg1-containing SWI/SNF remodeling 
complex in primary human T cells to upregulate interferon gamma (Ifng) expression [39], 
independent of its demethylase activity [39]. It is therefore plausible that UTX may play 
both a demethylase-dependent and independent role in T cell subset differentiation. Indeed, 
ChIP-seq experiments in UTX-deficient T cells reveal several gene loci for which gene 
expression is differentially regulated, but no H3K27 methylation changes were detected 
[19••, 38••]. Further investigation is needed to determine whether gene expression in TS T 
cells is also regulated by demethylase-independent UTX function.
Conclusions and Future Directions
TS association with chronic OM is well-recognized, but whether immune abnormalities 
contribute to this association had not been established. Recent gene expression profiling 
suggests alterations in TS immune cells and, in particular, highlighted reduced T cell 
expression of UTX, which may lead to decreased Tfh cells in TS. Of note, genetic 
deficiency of the UTX gene results in the genetic disorder Kabuki syndrome (KS), a rare 
congenital disorder that is also associated with recurrent OM [19••, 20]. Furthermore, 
reduced immunoglobulin levels, hypogammaglobulinemia, poor vaccine response, and 
reduced memory T and B lymphocytes have also been reported in KS [40, 41]. These 
associations in KS lend support to the role of UTX in regulating T cell development and 
immune function.
Recent inroads into understanding the TS immune system also provoke a number of 
questions. First, how does reduced UTX expression affect other immune cells in TS? It is 
important to note that the role of UTX was studied in a mouse model in which UTX was 
lacking in T cells. Whether UTX also regulates other immune cell lines, such as B cells, 
dendritic cells, macrophages, and neutrophils, is still unclear and requires further study. 
Second, does reduced UTX expression contribute to TS predisposition to autoimmunity? 
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Autoimmune hypothyroidism and celiac disease are strongly associated with TS, and what 
underlies this predisposition to autoimmunity is controversial. In one study, defective 
regulatory T cells (Tregs) that fail to inhibit proliferation of effector T cells were described 
in TS patients [18•]. Another study, however, found no difference in Treg frequencies or 
function in TS patients [42]. Thus, the mechanism underlying TS predisposition to 
autoimmunity remains to be defined.
Third, how do other epigenetic alterations regulate immune cells in TS? Recently, altered 
DNA methylation patterns, another type of epigenetic modification, of multiple autosomal 
genes involved in bone remodeling, glucose sensitivity, and ovarian function were reported 
to be altered in TS [43•]. Thus, it is possible that multiple epigenetic mechanisms of gene 
regulation are dysregulated in TS. Whether changes in DNA methylation impact T cells in 
TS requires further study.
Finally, the finding of decreased Tfh cells in TS suggests impaired response to viruses and 
vaccines. How do TS patients respond to commonly administered vaccine? Should TS 
patients receive a different course of vaccination? These questions are best addressed in the 
context of vaccine administration so that a specific T cell response can be measured. 
Additionally, whether decreased immunoglobulins, possibly as a result of decreased Tfh 
cells, is a clinical feature of TS is currently unclear and deserves further exploration. If a 
proportion of TS subjects are found to have lower immunoglobulins, treatment with IVIG 
may be beneficial to these patients. Even though more work needs to be done in the field of 
immunity and TS, the discovery of UTX as a gene with decreased expression in TS immune 
cells and the mechanism by which UTX affects Tfh differentiation are important steps 
toward understanding immune alterations in TS.
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Fig. 1. 
a TS patients are haploinsufficient in pseudoautosomal genes including UTX. Because 
pseudoautosomal genes escape inactivation, they are expressed from two copies of the X 
chromosomes in 46XX females. They are also expressed on the Y chromosome, so they are 
expressed from two copies in 46XY males. In 45XO TS females, however, they are only 
expressed from one X chromosome, so they may be haploinsufficient in TS. b Model: UTX 
deficiency in TS patients predisposes to chronic viral infection due to impaired Tfh 
differentiation. In 46XX females haplosufficient for UTX, Tfh cells differentiate from naïve 
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CD4+ T cells through UTX-specific H3K27 demethylase activity. H3K27 demethylation 
results in increased expression of Tfh-specific genes and adequate Tfh help for B cell 
maturation, anti-viral antibody production, and virus clearance. However, in TS patients and 
in UTX-deficient mice, UTX haploinsufficiency results in decreased circulating Tfh cells 
due to H3K27methylation and transcriptional suppression of Tfh-specific genes. Decreased 
Tfh cells in turn reduces B cell antibody production and prolongs chronic infection
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Table 1
Characteristics and comorbidities in Turner syndrome
Characteristic Prevalence (%)
Growth abnormalities 90
  – Short stature
Reproductive abnormalities 90
  – Ovarian failure
Dermatologic abnormalities 90
  – Multiple pigmented nevi
  – Edema of the extremities
  – Vitiligo
  – Alopecia
Neck abnormalities 70
  – Webbed neck
  – Low posterior hairline
Chest abnormalities 70
  – Shield chest
  – Wide spaced nipples
Otologic abnormalities 50
  – Otitis media
  – Hearing loss
  – Low set ears
Renal abnormalities 50
  – Horseshoe kidney
  – Renal agenesis
Cardiovascular abnormalities 50
  – Coartaction of the aorta
  – Hypertension
  – Bicuspid aortic valve
Skeletal abnormalities 50
  – Short 4th metacarpals
  – Madelung deformities
  – Cubitus valgus
Endocrine abnormalities 50
  – Autoimmune hypothyroidism
  – Carbohydrate intolerance
Gastrointestinal abnormalities 30
  – Fatty liver disease
  – Celiac disease
Clinical characteristics of TS patients and their prevalence. Potential immune-mediated findings are highlighted in italics. Characteristics secondary 
to lymphatic obstruction are in underline. Reference: [44]
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